AIS1
MCID: ATM052
MIFTS: 37

Autoimmune Disease 1 (AIS1)

Categories: Genetic diseases

Aliases & Classifications for Autoimmune Disease 1

MalaCards integrated aliases for Autoimmune Disease 1:

Name: Autoimmune Disease 1 56 73 29 6
Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 2 56 73
Autoimmune Disease, Susceptibility to, 1 56 13
Autoimmune Diseases 43 71
Vamas2 56 73
Ais1 56 73
Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 2; Vamas2 56
Autoimmune Disease Susceptibility Locus, Chromosome 1p-Related 56
Autoimmune Disease Susceptibility Locus Chromosome 1p-Related 73
Vitiligo-Associated Multiple Autoimmune Disease Type 2 73
Autoimmune Disease, Susceptibility to, Type 1 39
Autoimmune Disease Susceptibility 1 73

Characteristics:

OMIM:

56
Inheritance:
autosomal dominant

Miscellaneous:
early age at onset (13 years)


HPO:

31
autoimmune disease 1:
Inheritance autosomal dominant inheritance


Classifications:



External Ids:

OMIM 56 607836
MeSH 43 D001327
MedGen 41 C1842979
SNOMED-CT via HPO 68 21983002 263681008 56727007
UMLS 71 C0004364

Summaries for Autoimmune Disease 1

UniProtKB/Swiss-Prot : 73 Autoimmune disease 1: An autoimmune disorder characterized by the association of vitiligo with autoimmune thyroiditis (Hashimoto thyroiditis).

MalaCards based summary : Autoimmune Disease 1, also known as vitiligo-associated multiple autoimmune disease susceptibility 2, is related to autoimmune disease 6 and autoimmune disease, multisystem, with facial dysmorphism. An important gene associated with Autoimmune Disease 1 is FOXD3 (Forkhead Box D3). The drugs Ledipasvir and Sofosbuvir have been mentioned in the context of this disorder. Affiliated tissues include thyroid, t cells and bone, and related phenotypes are hashimoto thyroiditis and vitiligo

More information from OMIM: 607836

Related Diseases for Autoimmune Disease 1

Diseases related to Autoimmune Disease 1 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1311)
# Related Disease Score Top Affiliating Genes
1 autoimmune disease 6 12.6
2 autoimmune disease, multisystem, with facial dysmorphism 12.5
3 autoimmune disease, multisystem, infantile-onset, 1 12.5
4 autoimmune disease, multisystem, infantile-onset, 2 12.4
5 autoimmune disease 4 12.4
6 autoimmune disease of peripheral nervous system 12.3
7 systemic autoimmune disease 12.3
8 autoimmune disease of central nervous system 12.1
9 autoimmune disease of endocrine system 12.1
10 autoimmune disease of exocrine system 12.1
11 autoimmune disease of eyes, ear, nose and throat 12.1
12 autoimmune disease of gastrointestinal tract 12.1
13 autoimmune disease of musculoskeletal system 12.1
14 autoimmune disease of skin and connective tissue 12.1
15 autoimmune disease of urogenital tract 12.1
16 autoimmune disease of blood 12.1
17 autoimmune disease of cardiovascular system 12.1
18 secondary neonatal autoimmune disease 12.1
19 sjogren's syndrome, juvenile, secondary to autoimmune disease 12.1
20 inflammatory and autoimmune disease with epilepsy 12.1
21 autoimmune disease with skin involvement 12.1
22 postinfectious autoimmune disease with chorea 12.1
23 vitiligo-associated multiple autoimmune disease susceptibility 1 11.7
24 itch e3 ubiquitin ligase deficiency 11.7
25 sjogren syndrome 11.6
26 celiac disease 6 11.5
27 graves' disease 11.5
28 celiac disease 1 11.5
29 pemphigus 11.5
30 rheumatoid arthritis 11.5
31 mixed connective tissue disease 11.5
32 myasthenia gravis 11.5
33 primary biliary cirrhosis 11.4
34 undifferentiated connective tissue disease 11.4
35 stiff-person syndrome 11.4
36 goodpasture syndrome 11.4
37 scleroderma, familial progressive 11.4
38 multiple sclerosis 11.4
39 autoimmune hepatitis 11.4
40 igg4-related disease 11.4
41 neuromyelitis optica 11.4
42 interstitial lung disease 11.4
43 microscopic polyangiitis 11.4
44 lambert-eaton myasthenic syndrome 11.3
45 vogt-koyanagi-harada disease 11.3
46 cold agglutinin disease 11.3
47 dermatomyositis 11.3
48 premature ovarian failure 1 11.3
49 polymyositis 11.3
50 juvenile rheumatoid arthritis 11.3

Graphical network of the top 20 diseases related to Autoimmune Disease 1:



Diseases related to Autoimmune Disease 1

Symptoms & Phenotypes for Autoimmune Disease 1

Human phenotypes related to Autoimmune Disease 1:

31
# Description HPO Frequency HPO Source Accession
1 hashimoto thyroiditis 31 HP:0000872
2 vitiligo 31 HP:0001045

Symptoms via clinical synopsis from OMIM:

56
Skin Nails Hair Skin:
vitiligo, generalized
depigmentation, slowly progressive and diffuse

Endocrine Features:
hashimoto thyroiditis (some patients)

Clinical features from OMIM:

607836

Drugs & Therapeutics for Autoimmune Disease 1

Drugs for Autoimmune Disease 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 487)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ledipasvir Approved Phase 4 1256388-51-8 67505836
2
Sofosbuvir Approved Phase 4 1190307-88-0 45375808
3
Simvastatin Approved Phase 4 79902-63-9 54454
4
Dimethyl fumarate Approved, Investigational Phase 4 624-49-7 5271565 637568
5
Azithromycin Approved Phase 4 83905-01-5 447043 55185
6
Angiotensin II Approved, Investigational Phase 4 4474-91-3, 11128-99-7, 68521-88-0 172198
7
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
8
Azathioprine Approved Phase 4 446-86-6 2265
9
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
10
Zinc Approved, Investigational Phase 4 7440-66-6 32051
11
Lamivudine Approved, Investigational Phase 4 134678-17-4 60825
12
Insulin aspart Approved Phase 4 116094-23-6 16132418
13
Insulin glargine Approved Phase 4 160337-95-1
14
Entecavir Approved, Investigational Phase 4 142217-69-4 153941
15 Strawberry Approved Phase 4
16 Orange Approved Phase 4
17 Artichoke Approved Phase 4
18
Peginterferon alfa-2b Approved Phase 4 99210-65-8, 215647-85-1
19
Adalimumab Approved Phase 4 331731-18-1 16219006
20
Methotrexate Approved Phase 4 59-05-2, 1959-05-2 126941
21
Infliximab Approved Phase 4 170277-31-3
22
Etanercept Approved, Investigational Phase 4 185243-69-0
23
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
24
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
25
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
26 Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
27
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
28
Artesunate Approved, Investigational Phase 4 88495-63-0 6917864 5464098
29
Progesterone Approved, Vet_approved Phase 4 57-83-0 5994
30
Hydroxychloroquine Approved Phase 4 118-42-3 3652
31
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
32
Cephalexin Approved, Investigational, Vet_approved Phase 4 15686-71-2 27447
33
Naproxen Approved, Vet_approved Phase 4 22204-53-1 1302 156391
34
Povidone Approved Phase 4 9003-39-8
35
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
36
Calcitriol Approved, Nutraceutical Phase 4 32222-06-3 5280453 134070
37
Melatonin Approved, Nutraceutical, Vet_approved Phase 4 73-31-4 896
38
Tenofovir Experimental, Investigational Phase 4 147127-20-6 464205
39
Adefovir Investigational Phase 4 106941-25-7
40
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
41 Rosuvastatin Calcium Phase 4 147098-20-2
42 Hypolipidemic Agents Phase 4
43 Lipid Regulating Agents Phase 4
44 Anticholesteremic Agents Phase 4
45 Vasoconstrictor Agents Phase 4
46 Angiotensin II Type 1 Receptor Blockers Phase 4
47 Angiotensinogen Phase 4
48 Angiotensin Receptor Antagonists Phase 4
49 Giapreza Phase 4
50 interferons Phase 4

Interventional clinical trials:

(show top 50) (show all 869)
# Name Status NCT ID Phase Drugs
1 A Phase 4, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 and 4 HCV Infection With Autoimmune Disease Unknown status NCT02691728 Phase 4 LDV/SOF FDC
2 Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential Unknown status NCT02419378 Phase 4 Alemtuzumab
3 Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in SLE Patients With Corticosteroid Therapy and High LDL Cholesterol Level Unknown status NCT00866229 Phase 4 Rosuvastatin;Simvastatin
4 Calcitriol in the Treatment of Immunoglobulin A Nephropathy Unknown status NCT00862693 Phase 4 Calcitriol
5 A Phase IV, Single-site, Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum Unknown status NCT02199925 Phase 4 Gammaplex 5%
6 Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients Unknown status NCT03092544 Phase 4 dimethyl fumarate
7 Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Unknown status NCT01151644 Phase 4
8 Tacrolimus Treatment for Refractory Pure Red Cell Aplasia, a Prospective Study Unknown status NCT03540472 Phase 4 tacrolimus
9 Sirolimus Treatment for Refractory Pure Red Cell Aplasia, a Prospective Study Unknown status NCT03364764 Phase 4 Sirolimus
10 Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy:a Single Center Prospective Randomized Controlled Study Unknown status NCT02765594 Phase 4 Hydroxychloroquine Sulfate;Valsartan
11 Open Label Study of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease Unknown status NCT01469702 Phase 4 prednison and azithromycin;prednison, azithromycin;prednison, Azenil
12 Evaluation of Vaccination Against Influenza (Seasonal and H1N1) in Patients Presenting Systemic or Autoimmune Diseases Treated or Not With Steroids, and/or Immunosuppressant, and/or Biotherapy: an Open, Prospective Trial (MAIVAX) Completed NCT01065285 Phase 4
13 A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease) Completed NCT00304291 Phase 4 Mitoxantrone
14 Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases Completed NCT02040116 Phase 4 Rituximab Infusion
15 Influence of Plasma Exchange Therapy on the Pharmacokinetics of Rituximab in Patients Treated for Autoimmune Disorders. Completed NCT00820469 Phase 4 Rituximab 375;rituximab 1000
16 Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease Completed NCT00815282 Phase 4
17 A Phase 4, Multi-Center, Randomized, Open-Label Study to Evaluate the Effect of BENLYSTA™ (Belimumab; HGS1006) on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE) Completed NCT01597492 Phase 4
18 Prospective, Randomized, Double Blind Placebo Controled Clinical Trial to Assess the Multi- Systemic Effect of Vitamin D Supplementation on Young Men With Vitamin D Deficiency Completed NCT01016184 Phase 4
19 Use of Vitamin D in Treatment of Non-Alcoholic Fatty Liver Disease Detected by Transient Elastography Completed NCT04038853 Phase 4 1,25-Dihydroxyvitamin D;Placebo
20 Effect of Ergocalciferol Repletion on Urine Calcium Among Stone Formers With Vitamin D Deficiency and Hypercalciuria Completed NCT01295879 Phase 4 Ergocalciferol
21 Multicenter Randomized Clinical Trial in Patients With Juvenile Idiopathic Arthritis: Safety and Efficacy of Vaccination With Live Attenuated Measles, Mumps, Rubella Vaccine Completed NCT00731965 Phase 4
22 The Effect of Insulin Degludec on Risk of Symptomatic Nocturnal Hypoglycaemia in Subjects With Type 1 Diabetes and High Risk of Nocturnal Severe Hypoglycaemia Completed NCT02192450 Phase 4 Insulin aspart/glargine;Insulin aspart/degludec
23 Pneumococcal Vaccination of Crohn Patients - A Randomized, Non-blinded Phase 4 Clinical Trial With the Purpose of Investigating the Immune Response Against Two Different Pneumococcal Vaccines in Patients With Crohn's Disease Completed NCT01947010 Phase 4
24 A Placebo Controlled Trial of Amoxicillin for Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections Completed NCT00001658 Phase 4 Amoxicillin
25 Comparison of Two Standard High-dose Treatment Regimens for Vitamin D Deficiency in Minority Adolescents: Associations of Vitamin D Repletion With Changes in Markers of Musculoskeletal, Cardiometabolic, and Immune Function Completed NCT01784029 Phase 4 Vitamin D3
26 EFFECTS OF A DIET RICH IN N-3 POLYUNSATURATED FATTY ACIDS ON SYSTEMIC INFLAMMATION IN RENAL TRANSPLANT RECIPIENTS Completed NCT01872455 Phase 4
27 SWITCH OR ADD PEGYLATED-INTERFERON IN CHRONIC HEPATITIS B PATIENTS ON LONG TERM NUCLEOS(T)IDE THERAPY (SWAP TRIAL) Completed NCT01928511 Phase 4 peg-interferon alpha 2b, 1.5mcg/kg s/c given weekly;Nucleos(t)ide analogue therapy
28 Is Dietary Melatonin Supplementation a Viable Adjunctive Therapy for Chronic Periodontitis? A Preliminary Randomized Clinical Trial. Completed NCT03368430 Phase 4 Placebo
29 Effect Of Hormone Replacement Therapy On Disease Activity, Menopausal Symptoms And Bone Mineral Density In Peri/Postmenopausal Women With Systemic Lupus Erythematosus.Randomized Clinical Trial Completed NCT00392093 Phase 4 Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d
30 Patient-Reported AutoImmunity Secondary to Cancer immunothErapy Recruiting NCT03849131 Phase 4
31 Relevance of Monitoring Blood Levels Compared to Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases: Adherence and Understanding the Possible Underlying Mechanisms Involved in Effectiveness and in Adverse Effects Recruiting NCT03122431 Phase 4 Thalidomide;Hydroxychloroquine reduced;Hydroxychloroquine high
32 A Multicenter, Randomized Controlled Clinical Study About Efficacy and Safety of Standard Dose and Individualized Dose of Rituximab in Maintaining Remission in Patients With Moderate to Severe Systemic Lupus Erythematosus Recruiting NCT04127747 Phase 4 Standard dose of rituximab;Individualized dose of rituximab
33 Effect of Hydroxychloroquine on Endothelial Function: a Clinical Trial Recruiting NCT04161339 Phase 4 Hydroxychloroquine;Placebo oral tablet
34 A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis: Pilot Study Recruiting NCT03214731 Phase 4 Artesunate
35 Silymarin® - Efficacy in Treatment of Non-alcoholic Fatty Liver Disease (NAFLD) Controlled by Laboratory and and Elastographic Parameters Recruiting NCT02973295 Phase 4 Silymarin
36 Adalimumab Dose Reduction Aiming Low Serum Concentration With Control of Disease Activity: a Single Blind, Non-inferiority, Randomised Clinical Trial Recruiting NCT04222920 Phase 4 Adalimumab
37 Efficacy of Fractional CO2 Laser Alone and as Transepidermal Drug Delivery for Different Modalities of Treatment in Alopecia Areata Recruiting NCT04003376 Phase 4 Triamcinolone Acetonide 10mg/mL;vitamin D solution
38 Stopping Tumor Necrosis Factor-Alpha Inhibitors in Rheumatoid Arthritis (STARA) Clinical Trial Recruiting NCT01793519 Phase 4 Etanercept;Infliximab;Adalimumab;Placebo
39 Rituximab (RTX) Therapy in Steroid Resistant Patients or Patients Relapsing After Intravenous Steroids With Active TAO Recruiting NCT02378298 Phase 4 Rituximab;Iv Methylprednisolone;peroral methylprednisolone and Methotrexate
40 A Multi-site, Open-Label, Pilot Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) Active, not recruiting NCT03348618 Phase 4
41 Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease. Impact of Antirheumatic Treatment on Antibody Response. Active, not recruiting NCT03762824 Phase 4
42 Lactoferrin or Progesterone for Prevention of Preterm Delivery Active, not recruiting NCT02372942 Phase 4 Lattoferrin;Progesterone
43 Antibiotic Prophylaxis in High-Risk Arthroplasty Patients Not yet recruiting NCT04297592 Phase 4 Cephalexin Oral Tablet;Doxycycline Hyclate
44 Double-Blind, Randomized, Placebo-Controlled Trial of Naproxen Sodium for the Treatment of Obsessive Compulsive Symptoms in Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcal Infections (PANDAS) Not yet recruiting NCT04015596 Phase 4 Naproxen Sodium
45 Hydroxychloroquine in ANCA Vasculitis Evaluation - A Multicentre, Randomised, Double-blind, Placebo-controlled Trial Not yet recruiting NCT04316494 Phase 4 Hydroxychloroquine;Placebo
46 A Phase 4 Multicenter, Randomized, Placebo Controlled Trial of 3 Doses of Intralesional Triamcinolone (KENALOG®) In the Treatment of Mild to Moderate Patch Type Alopecia Areata Terminated NCT01898806 Phase 4 Intralesional Triamcinolone 2.5 mg/ml;Intralesional Triamcinolone 5 mg/ml;Intralesional Triamcinolone 10 mg/ml;Intralesional Saline
47 Remission Keeping and Remission Inducing Effect by Vitamin-D in Crohns Disease, and in Vitro Vitamin-D Mediated T-Cell Immunomodulation Unknown status NCT00132184 Phase 2, Phase 3 Vitamin D
48 A Study of a Topical Formulation of Nitroglycerin, MQX-503, and Matching Vehicle in the Treatment and Prevention of Raynaud's Phenomenon Unknown status NCT00577304 Phase 3 Nitroglycerin;Topical AmphiMatrix
49 Prospective, Double-blind, Randomised, Placebo-controlled, Cross-over Study to Investigate the Effect of Intravenous Immunoglobulins on Complex Regional Pain Syndrome (CRPS, M. Sudeck) Unknown status NCT00949065 Phase 3
50 Ultrasound Scores as Imaging Biomarkers of Early Response to Subcutaneous Tocilizumab in Association With Methotrexate in Very Early Rheumatoid Arthritis (TOVERA) Unknown status NCT02837146 Phase 3 Methotrexate (MTX)

Search NIH Clinical Center for Autoimmune Disease 1

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Methylprednisolone
methylprednisolone acetate
Methylprednisolone Sodium Succinate
Prednisone
PREDNISONE PWDR

Cochrane evidence based reviews: autoimmune diseases

Genetic Tests for Autoimmune Disease 1

Genetic tests related to Autoimmune Disease 1:

# Genetic test Affiliating Genes
1 Autoimmune Disease 1 29 FOXD3

Anatomical Context for Autoimmune Disease 1

MalaCards organs/tissues related to Autoimmune Disease 1:

40
Thyroid, T Cells, Bone, B Cells, Breast, Testes, Bone Marrow

Publications for Autoimmune Disease 1

Articles related to Autoimmune Disease 1:

(show all 26)
# Title Authors PMID Year
1
Candidate functional promoter variant in the FOXD3 melanoblast developmental regulator gene in autosomal dominant vitiligo. 6 56
16098053 2005
2
A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. 56 61
12707860 2003
3
Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. 56 61
11912181 2002
4
Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. 56
10599734 1999
5
A 6-year survey of road traffic accidents in Southwest China: Emphasis on traumatic brain injury. 61
32563388 2020
6
Far Side Impact Injury Threshold Recommendations Based on 6 Paired WorldSID / Post-Mortem Human Subjects Tests. 61
32311054 2019
7
Characteristics of pedestrian head injuries observed from real world collision data. 61
31130209 2019
8
Genomics-Driven Immunoproteomics: An Integrative Platform to Uncover Important Biomarkers for Human Diseases. 61
31364060 2019
9
Immune mediated conditions in autism spectrum disorders. 61
25681541 2015
10
[INDICATIONS FOR ANTITHROMBOTIC MEDICATION DURING PREGNANCY--ANALYSIS OF CURRENT PRACTICES IN BULGARIA]. 61
26411189 2015
11
Airway management and endoscopic treatment of subglottic and tracheal stenosis: the laryngeal mask airway technique. 61
24671485 2014
12
Bicycle helmet wearing and the risk of head, face, and neck injury: a French case--control study based on a road trauma registry. 61
21606469 2012
13
[II. Autoimmune disease: 1. Systemic lupus erythematosus]. 61
21702138 2011
14
Unusual association between adrenal leiomyoma and autoimmune disease. 61
20174739 2010
15
Collagenous gastritis: histopathologic features and association with other gastrointestinal diseases. 61
19295410 2009
16
Biosynthesis of t-anethole in anise: characterization of t-anol/isoeugenol synthase and an O-methyltransferase specific for a C7-C8 propenyl side chain. 61
18987218 2009
17
Risk of permanent medical impairment (RPMI) in road traffic accidents. 61
19026226 2008
18
Minor crashes and 'whiplash' in the United States. 61
19026229 2008
19
Evidence for two susceptibility loci on chromosomes 22q12 and 6p21-p22 in Chinese generalized vitiligo families. 61
17568780 2007
20
Motor vehicle restraint system use and risk of spine injury. 61
16990240 2006
21
The first three years of the Swiss Neuropaediatric Stroke Registry (SNPSR): a population-based study of incidence, symptoms and risk factors. 61
15822021 2005
22
Influence of Airbags and Seatbelt Pretensioners on AIS1 Neck Injuries for Belted Occupants in Frontal Impacts. 61
17458722 2000
23
A Study of AIS1 Neck Injury Parameters in 168 Frontal Collisions Using a Restrained Hybrid III Dummy. 61
17458721 2000
24
Neck injuries in frontal impacts: influence of crash pulse characteristics on injury risk. 61
10688476 2000
25
CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. 61
9974060 1999
26
[Aortic valve replacement using aortic donor valves of human origin]. 61
8145864 1994

Variations for Autoimmune Disease 1

ClinVar genetic disease variations for Autoimmune Disease 1:

6 ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 FOXD3 FOXD3, -639G-TSNV risk factor 889

Expression for Autoimmune Disease 1

Search GEO for disease gene expression data for Autoimmune Disease 1.

Pathways for Autoimmune Disease 1

GO Terms for Autoimmune Disease 1

Sources for Autoimmune Disease 1

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....